Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology
J Neurol Neurosurg Psychiatry
.
2020 Aug 27:jnnp-2020-324291.
doi: 10.1136/jnnp-2020-324291.
Online ahead of print.
Authors
Luke Dixon
1
,
Charles Coughlan
2
,
Kushan Karunaratne
3
,
Nikolaos Gorgoraptis
3
4
,
James Varley
3
,
James Husselbee
2
,
Dermot Mallon
5
,
Roseita Carroll
2
,
Brynmor Jones
5
,
Claire Boynton
2
,
Jane Pritchard
3
,
Taryn Youngstein
6
,
Justin Mason
7
,
Carolyn Gabriel
3
Affiliations
1
Department of Imaging, Imperial College Healthcare NHS Trust, London, UK
[email protected]
.
2
Department of Anaesthetics, Imperial College Healthcare NHS Trust, London, UK.
3
Department of Neurology, Imperial College Healthcare NHS Trust, London, UK.
4
Department of Brain Sciences, Imperial College London, London, UK.
5
Department of Imaging, Imperial College Healthcare NHS Trust, London, UK.
6
Department of Rheumatology, Imperial College Healthcare NHS Trust, London, UK.
7
National Heart and Lung Institute, Imperial College London, London, UK.
PMID:
32855293
DOI:
10.1136/jnnp-2020-324291
No abstract available
Keywords:
infectious diseases; neuroimmunology; stroke.
Publication types
Letter